Uterine sex cord tumour- Management dilemma by Mohamad Nasir S, et al.
Uterine sex cord tumour                                                                                                                                          Mohamad NS et al. 
 
7 
 
 
 
 
 
 
Uterine Sex Cord Tumour- Management Dilemma 
 
Mohamad Nasir S
1
(), Lim PS1, Swaminathan M2, Hatta MD1, Mohd Hashim O1 
 
1
Department of Obstetrics and Gynaecology, 
2 
Department of Pathology, Universiti Kebangsaan Malaysia    
 Medical Center, Jalan Yaacob Latiff, 56000 Cheras, Kuala Lumpur 
  
Abstract 
 
Uterine sex cord tumour is a very rare tumour with uncertain management strategies and prognosis. A 61-year-old, 
nulliparous, who was not on hormone replacement therapy, presented with first episode of postmenopausal bleeding. 
A transvaginal scan revealed an enlarged uterus with thick endometrial lining and features of multiple degenerated 
fibroid. Endometrial biopsy was negative for malignancy. Computed tomography of the abdomen and pelvis 
confirmed the mass, with atrophic ovaries and incidental finding of bilateral hydronephrosis requiring stentings. 
Otherwise, there were no pelvic lymph nodes enlargement. Our impression was a uterine sarcoma and we decided for 
total abdominal hysterectomy with bilateral salpingooophorectomy. Surprisingly, the histology report confirmed 
uterine sex cord tumour. There are less cases of recurrence and there is no general consensus on the management. 
However, we decided for adjuvant chemotherapy (BEP regime) as the malignant cells infiltrated more than half of 
myometrial thickness, with good outcome. 
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Introduction 
 
Uterine malignancy of sex-cord-like elements is 
extremely rare. It accounts for 0.25% of all uterine 
neoplasm (1). There were about 48 cases being 
reported to date (2). Due to its rarity, it possess 
diagnostic difficulties, treatment options and limited 
data on the recurrence and disease outcome. 
 
The tumour was first discovered in 1945 by Morehead 
and Bowman and further evaluated by Clement and 
Scully in 1976. It is described as epithelial-like or sex 
cord like elements, often with epithelioid appearance, 
arranged in nests, cords, trabeculae, solid, or tubular 
structures. If this element predominates, the tumour is 
considered to be a uterine tumour resembling ovarian 
sex cord tumour (UTROSCTs) (1, 3).   
Case report  
 
A case of 61-year-old woman, nulliparous, who was 
not on hormone replacement therapy presented with 
first episode of post-menopausal bleeding. Otherwise, 
there was no history of vaginal discharge, 
constitutional or compressive symptoms. She was not 
known significant medical or family history. She had 
an appropriate body mass index, no palpable lymph 
nodes. A sixteen weeks size uterine mass felt with 
multilobulated surface, firm in consistency and it was 
not fixed. Ovaries were not palpable and there were no 
ascites nor hepatosplenomegaly. 
 
Ultrasound scan revealed an enlarged uterus with 
evidence of multiple degenerated fibroids, 6 mm 
endometrial thickness and atrophic ovaries. No ascites
Case report 
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or swelling was noted.  Doppler study was not 
suggestive of malignancy as sarcoma was one of our 
differential diagnosis. Endometrial biopsy excluded 
neoplasia. Computed tomography of abdomen and 
pelvis were performed as uterine sarcoma was highly 
suspected in this case, and incidentally she was found 
to have bilateral hydronephrosis, and required 
stentings. 
 
Total abdominal hysterectomy with bilateral salpingo-
oophorectomy were performed. Intraoperatively, no 
ascites was found with healthy omentum. 
Multilobulatedly enlarged uterus with presence of 
cystic areas at 16 weeks size was found. A few small, 
calcified  subserosal fibroids were seen and both 
ovaries were atrophic. 
 
Microscopically, there was highly cellular tumour 
forming focal tubular and glandular-like-structures 
with diffused multiple hemorrhagic and necrotic areas. 
The tumour composed of generally-uniform spindle 
shaped cells with vesicular nuclei and prominent 
nucleoli. The malignant cells infiltrated more than half 
of the myometrial wall thickness but did not penetrate 
the serosal layer. Immunohistochemical staining for 
CK, CK 7, Vimentin and EMA was positive but 
inconclusive or CD 99. There was no invasion to 
cervix, parametrial or paracervical tissues. Both 
fallopian tubes and ovaries were normal. The findings 
were consistent with malignant sex-cord tumour of the 
uterus. 
 
A course of four cycles adjuvant chemotherapy 
consisting bleomycin, etoposide and cisplatin (BEP 
regime) was given four weeks postoperatively with 
good result and no evidence of tumour recurrence.  
 
Discussion 
 
Endometrial stromal tumour has two variants which is 
combined smooth muscle stromal tumour and uterine 
neoplasm resembling an ovarian sex cord tumour 
(UTROSCT) (4). The later is extremely uncommon 
variant and due to its rarity. There is no established 
protocol, management consensus and prognostication 
on the disease.  
 
The WHO publication classifies UTROSCT as 
miscellaneous tumour rather than endometrial stromal 
tumour group, yet the management strategies remains 
debatable. The role of radical hysterectomy and 
bilateral salpingo-oophorectomy in this case was not 
known but in this case we performed less morbidity 
approach-non radical surgery, which had promising 
results.  
 
There is a published case of potential tumour 
recurrence or even a metastasis especially if the 
tumours are invasive (5). Therefore, adjuvant 
treatment namely chemotherapy would be an 
acceptable modality especially poorly circumscribed 
borders with possible focal vascular invasion. Even 
though in some publications reported no recurrence, 
the time frame was limited and no conclusion could be 
drawn (5). As this case was extremely rare and there is 
no established data on this issue, we opted for BEP 
chemotherapy which she agreed upon, and it was with 
good acceptance. 
 
Biochemical monitoring for disease recurrence is not 
established. However, we hope serum inhibin would 
be sensitive and specific with low false positive value  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Histopathologic appearance of the tumour; (a) Tubules and cord like epithelial structures of the tumour (b) Foamy 
tumour cells 
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albeit no supportive evidence of proof as the variant 
of the disease unrevealed.   
 
Conclusion 
 
The present case was rare and assumes much 
importance because of absence of unreported cases of 
recurrence and no general consensus on the further 
management and prognosis. We believe adjuvant 
chemotherapy has a role to reduce risk of tumour 
recurrence as observed in this case. 
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